Home / Pharmaceutical company intelligence
Medipak Limited logo
Pharmaceutical company intelligence

Medipak Limited

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Pharmaceutical and medical-device manufacturer · Lahore · Pakistan

Lahore-based manufacturer established in 1982, producing infusion solutions, IV sets, medical devices, ophthalmic products, solid dosage forms and injectables.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation27 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date17 Aug 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Pharmaceutical and medical-device manufacturer
Address
132/1, Quaid-e-Azam Industrial Estate, Kot Lakhpat, Lahore 54700, Pakistan · 54700
Phone
+92 42 111 017 017
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000257 Medipak Ltd. · Punjab
Formulation 000841 Medipak Ltd. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000257 103 linked products · source seen 27 Sep 2026 View source ↗
DML 000841 54 linked products · source seen 27 Sep 2026 View source ↗
Corporate profile source ledger Logo Url source ↗ Contact Page Url source ↗ Logo Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx163public portfolio records represented
REG137unique registrations represented
IDX157indexed MedInfoBase presentations
SRC6additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR158current validated price records
G47generic molecules in indexed catalogue
DF8dosage-form groups
TA10therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage97%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage99%
priced packs safely normalized per unit
Comparable-market coverage59%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixMedipak LimitedShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/medipak-limitedGenerated 27 Sep 2026Fluids & supportive care96 · 61%Anti-infectives24 · 15%Hematology & thrombosis14 · 9%Ophthalmology7 · 4%Cardiovascular6 · 4%Respiratory & allergy4 · 3%Vitamins, minerals & nutrition3 · 2%Other therapeutic areas3 · 2%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioMedipak LimitedDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/medipak-limitedGenerated 27 Sep 2026157presentationsInfusion68 · 43%Injection34 · 22%Tablet25 · 16%Solution14 · 9%Drops10 · 6%Other3 · 2%Other forms3 · 2%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionMedipak LimitedCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/medipak-limitedGenerated 27 Sep 202693comparable productsBelow peer median21 · 23%Near peer median30 · 32%Above peer median42 · 45%Company median price position+2.3%Lowest-price equivalents9Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsMedipak LimitedCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/medipak-limitedGenerated 27 Sep 2026Searle IV Solutions (Pvt) Ltd.21 shared45% overlapZafa Pharmaceutical Laboratories (P…20 shared43% overlapNeutro Pharma (Pvt.) Ltd.,20 shared43% overlapEpharm Laboratories19 shared40% overlapNabiqasim Industries (Pvt) Ltd.,18 shared38% overlapBosch Pharmaceuticals (Pvt) Ltd.18 shared38% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Fluids & supportive care96 products · 61%
Anti-infectives24 products · 15%
Hematology & thrombosis14 products · 9%
Ophthalmology7 products · 4%
Cardiovascular6 products · 4%
Respiratory & allergy4 products · 3%
Vitamins, minerals & nutrition3 products · 2%
Endocrine & metabolic1 products · 1%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Fluids, electrolytes & diluents96 products · 61%
Fluoroquinolone antibacterials11 products · 7%
Erythropoiesis-stimulating agents11 products · 7%
Glaucoma medicines6 products · 4%
Nitroimidazole anti-infectives4 products · 3%
Antimalarials4 products · 3%
Aminoglycoside antibacterials3 products · 2%
Vitamins / minerals / hematinics3 products · 2%
Formulation footprint

Dosage forms

Infusion68 products
Injection34 products
Tablet25 products
Solution14 products
Drops10 products
Other3 products
Capsule2 products
Sachet1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 EpogenErythropoietin 11presentations 1000 IU/2 mL, 10000 IU, 2000 IU, 20000 IU · Injection #2 CiprofenaCiprofloxacin 7presentations 200 mg, 200 mg/100 mL, 250 mg, 3 mg/mL · Infusion, Tablet, Drops #3 Medisol 1/2 NSSodium chloride 7presentations 0.45 g, 0.45% w/v · Infusion, Injection #4 Medisol DextroseDextrose 6presentations 10 %, 10%, 25%, 5 % · Infusion #5 Medisol NSSodium chloride 6presentations 0.9 g · Infusion #6 Medisol NS IVSodium chloride 6presentations 0.9 g, 0.9% w/v · Infusion
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where Medipak Limited is priced against the market

93 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Searle IV Solutions (Pvt) Ltd.102 products · 50 generics 21shared generics Zafa Pharmaceutical Laboratories (Pvt) Ltd.238 products · 97 generics 20shared generics Neutro Pharma (Pvt.) Ltd.,209 products · 97 generics 20shared generics

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers132Distinct registrations among indexed, published, presentation-validated products only
Verified price observations242
Products with a verified price157
Products with multiple price observations84
Source records with multiple versions157
Latest portfolio source check22 Sep 2026
Latest effective price date17 Aug 2026
Latest source observation27 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

137 unique registration(s) · 157 indexed presentation(s) · 6 additional source-observed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Medisol Hartmann’s Ringer's lactate solution NaCl 0.6g + KCl 0.04g + CaCl2 0.027g + Na lactate 0.32g/100 mL IV infusion 500ml 085202 PKR 163.79 PKR 0.33/mL 🔒 Pharma Pro
Medisol Hartmann’s Hartmann’s solution (compound sodium lactate) NaCl 0.6 g + KCl 0.04 g + CaCl2 0.027 g + Na lactate 0.64 g/100 mL IV infusion 1000ml 085203 PKR 198.74 PKR 0.20/mL No comparator
Medisol Hartmann’s Sodium chloride 0.6 g/100 mL IV infusion 120 ml 085203 PKR 189.38 PKR 1.58/mL No comparator
Medisol Hartmann’s Ringer's lactate solution NaCl 0.6g + KCl 0.04g + CaCl2 0.027g + Na lactate 0.32g/100 mL Injection 500ml 087871 PKR 163.79 PKR 0.33/mL No comparator
Medisol Hartmann’s Sodium chloride 0.6 g Injection 1000ml 087872 PKR 198.73 PKR 0.20/mL No comparator
Medisol Hartmann’s Ringer's lactate solution per 100 mL: NaCl 0.6 g + KCl 0.04 g + CaCl2·2H2O 0.027 g + sodium lactate (50%) 0.64 g IV infusion 250ml 106346 PKR 118.56 PKR 0.47/mL No comparator
Medisol Hartmann’s Ringer's lactate solution per 100 mL: NaCl 0.6 g + KCl 0.04 g + CaCl2·2H2O 0.027 g + sodium lactate (50%) 0.64 g IV infusion 250ml 106356 PKR 118.56 PKR 0.47/mL No comparator
Medisol Medilyte-M Dextrose 0.022 g + 0.150 g + 0.216 g + 0.313 g + 5 g / 100 mL IV infusion 1000ml 032220 PKR 197.27 PKR 0.20/mL 🔒 Pharma Pro
Medisol Medilyte-MSource observed Electrolytes + Dextrose NaCl 0.216g + KCl 0.150g + CaCl2 0.022g + Na acetate 0.313g + Dextrose 5g/100 mL IV infusion 500ml 057441Official source ↗ No indexed price — —
Medisol NS Sodium chloride 0.9 g IV infusion 100ml 008242 PKR 92.01 PKR 0.92/mL 🔒 Pharma Pro
Medisol NS Sodium chloride 0.9 g IV infusion 1000ml 008242 PKR 161.94 PKR 0.16/mL 🔒 Pharma Pro
Medisol NS Sodium chloride 0.9 g IV infusion 100ml 080356 PKR 110.40 PKR 1.10/mL 🔒 Pharma Pro
Medisol NS Sodium chloride 0.9 g IV infusion 1000ml 083353 PKR 182.18 PKR 0.18/mL 🔒 Pharma Pro
Medisol NS Sodium chloride 0.9 g IV infusion 100ml 083384 PKR 110.40 PKR 1.10/mL 🔒 Pharma Pro
Medisol NS Sodium chloride 0.9 g IV infusion 1000ml 084875 PKR 182.18 PKR 0.18/mL 🔒 Pharma Pro
Medisol NS IV Sodium chloride 0.9% w/v IV infusion 50ml 008242 PKR 60.03 PKR 1.20/mL 🔒 Pharma Pro
Medisol NS IV Sodium chloride 0.9% w/v IV infusion 500ml 008242 PKR 128.82 PKR 0.26/mL 🔒 Pharma Pro
Medisol NS IV Sodium chloride 0.9% w/v IV infusion 500ml 083352 PKR 149.06 PKR 0.30/mL 🔒 Pharma Pro
Medisol NS IV Sodium chloride 0.9% w/v IV infusion 500ml 084874 PKR 149.06 PKR 0.30/mL 🔒 Pharma Pro
Medisol NS IV Sodium chloride 0.9 g IV infusion 250ml 106338 PKR 105.05 PKR 0.42/mL 🔒 Pharma Pro
Medisol NS IV Sodium chloride 0.9 g IV infusion 250ml 106352 PKR 105.05 PKR 0.42/mL 🔒 Pharma Pro
Medisol Paed’s Dextrose + Sodium chloride 0.18% + 4.3% IV infusion 1000ml 087870 PKR 114.55 PKR 0.11/mL No comparator
Medisol Paed’s IV Dextrose + Sodium chloride NaCl 0.18g + Dextrose 4.3g/100 mL IV infusion 500ml 083358 PKR 139.62 PKR 0.28/mL 🔒 Pharma Pro
Medisol Paed’s IV Dextrose + Sodium chloride NaCl 0.18g + Dextrose 4.3g/100 mL IV infusion 500ml 084880 PKR 139.62 PKR 0.28/mL 🔒 Pharma Pro
Medisol Paed’s IV Sodium chloride 0.18 g IV infusion 250ml 106341 PKR 118.56 PKR 0.47/mL No comparator
Medisol Paed’s IV Sodium chloride 0.18 g IV infusion 250ml 106355 PKR 118.56 PKR 0.47/mL No comparator
Medisol Paeds Dextrose + Sodium chloride 0.18% + 4.3% IV infusion 1000ml 085219 PKR 114.55 PKR 0.11/mL No comparator
Medisol Peri-Hyper Isotonic Peritoneal dialysis solution NaCl 5.38 + CaCl2·2H2O 0.183 + MgCl2·6H2O 0.0508 + Na lactate 4.48 + dextrose 42.5 (g/L) Peritoneal dialysis solution 2000ml 009796 PKR 267.59 PKR 0.13/mL No comparator
Medisol Peri-Iso Isotonic Peritoneal dialysis solution NaCl 5.38 + CaCl2·2H2O 0.183 + MgCl2·6H2O 0.0508 + Na lactate 4.48 + dextrose 15 (g/L) Peritoneal dialysis solution 2000ml 009794 PKR 267.59 PKR 0.13/mL No comparator
Medisol Ringer's Ringer's solution 0.30 g Solution 1000ml 009693 PKR 155.94 PKR 0.16/mL No comparator
Medisol Ringer's Ringer's solution NaCl 8.60g + KCl 0.30g + CaCl2 0.33g/1000 mL Solution 500ml 009693 PKR 127.75 PKR 0.26/mL No comparator
Medisol S Dextrose + Sodium chloride 5% + 0.9% IV infusion 1000ml 008239 PKR 178.50 PKR 0.18/mL 🔒 Pharma Pro
Medisol S Sodium chloride 0.9 g IV infusion 1000ml 083357 PKR 198.73 PKR 0.20/mL 🔒 Pharma Pro
Medisol S Dextrose + Sodium chloride 5% + 0.9% IV infusion 1000ml 084879 PKR 198.73 PKR 0.20/mL 🔒 Pharma Pro
Medisol S IV Dextrose + Sodium chloride NaCl 0.9g + Dextrose 5g/100 mL IV infusion 500ml 008239 PKR 149.06 PKR 0.30/mL 🔒 Pharma Pro
Medisol S IV Dextrose + Sodium chloride NaCl 0.9g + Dextrose 5g/100 mL IV infusion 500ml 083356 PKR 169.29 PKR 0.34/mL 🔒 Pharma Pro
Medisol S IV Dextrose + Sodium chloride NaCl 0.9g + Dextrose 5g/100 mL IV infusion 500ml 084878 PKR 169.29 PKR 0.34/mL 🔒 Pharma Pro
Medisol S IV Sodium chloride 0.9 g IV infusion 250ml 106340 PKR 120.05 PKR 0.48/mL 🔒 Pharma Pro
Medisol S IV Sodium chloride 0.9 g IV infusion 250ml 106354 PKR 120.05 PKR 0.48/mL 🔒 Pharma Pro
Meditim Timolol 0.5 % Eye drops 5ml 004299 PKR 215.33 PKR 43.07/mL 🔒 Pharma Pro
Meditim Timolol 0.25 % Eye drops 5ml 025423 PKR 58.24 PKR 11.65/mL 🔒 Pharma Pro
Normasal Sodium chloride 0.9 % Injection 20ml 016932 PKR 2.20 PKR 0.11/mL 🔒 Pharma Pro
Oedemin Furosemide 20 mg Injection 2mlx50's 015629 PKR 280.36 PKR 2.80/mL 🔒 Pharma Pro
Panafin Paracetamol 500 mg Tablet 20x10’s 027706 PKR 618.43 PKR 3.09/tablet 🔒 Pharma Pro
Purisol Dextrose Dextrose 5% Irrigation solution 3000ml 016933 PKR 271.54 PKR 0.09/mL No comparator
Purisol Dextrose Dextrose 5 % Irrigation solution 5000ml 016933 PKR 463.81 PKR 0.09/mL No comparator
Purisol NS Sodium chloride 0.9% Irrigation solution 3000ml 014264 PKR 237.85 PKR 0.08/mL No comparator
Purisol NS Sodium chloride 0.9 % Irrigation solution 5000ml 014264 PKR 400.39 PKR 0.08/mL No comparator
Quodmed Chloroquine 250 mg Tablet 500's 107263 PKR 509.62 PKR 1.02/tablet 🔒 Pharma Pro
Quodmed-H-200mg Hydroxychloroquine 200 mg Tablet 50's 107262 PKR 594.11 PKR 11.88/tablet 🔒 Pharma Pro
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Medipak Limited — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 27, 2026, from https://medinfobase.com/company/medipak-limited/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.